Propafenone

پروپافنون

⚠ Unverified

❤️ Cardiovascular SystemClass IC antiarrhythmic

Market / country: 🇺🇸 USA

Rythmol (US)

🧮 Dose calculator

Atrial fibrillation / anticoagulation · Regimen source: FDA Propafenone · 2

  • • 150 mg every 8 h; after at least 3–4 days to 225 then 300 mg every 8 h. Not with structural heart disease. FDA Propafenone · 2

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

  • ⛔ Heart failure; cardiogenic shock; sinoatrial, AV or intraventricular conduction disorders without a pacemaker; Brugada syndrome; marked bradycardia or hypotension; bronchospastic disorders; electrolyte imbalance. FDA Propafenone · 4

Warnings

  • • Boxed warning: increased mortality (CAST); reserve for documented life-threatening or symptomatic arrhythmias without structural heart disease. FDA Propafenone · Boxed Warning

Formulations

👥 Special populations

  • 🤰 PregnancyUse with caution

    Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Propafenone · 8.1

    “Risk Summary There are no studies of propafenone hydrochloride in pregnant women.”
  • 🤱 BreastfeedingUse with caution

    Label: use with caution while breastfeeding; see the label text. FDA Propafenone · 8.2

    “Risk Summary Propafenone and its active metabolite, 5-OH-propafenone, are present in human milk, but the levels are likely to be low.”
  • 👶 ChildrenSafety not established

    Label: safety and effectiveness in children have not been established. FDA Propafenone · 8.4

    “The safety and effectiveness of propafenone in pediatric patients have not been established.”
  • 👴 Older adultsUse with caution

    Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Propafenone · 8.5

    “In general, dose selection for an elderly patients should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
  • ⚥ Females & males of reproductive potentialUse with caution

    Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Propafenone · 8.3

    “Infertility Males: Based on human and animal studies, propafenone hydrochloride may transiently impair spermatogenesis in males.”

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Same class

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Information on this site is compiled from online websites and references. Doz accepts no responsibility for self-medication without approval from a physician and a reliable reference, or for any consequences of using this information.

Inspired by the Saphira project; part of the content is taken from it.

For suggestions, corrections, adding drugs or anything else, you can contact me on Telegram: @cenaav